PharmaBro vs Bask Health: the 2026 comparison

PharmaBro charges a published flat platform fee and a transaction fee that runs at card-processing cost. That is the entire commercial relationship.

Bask charges a platform fee and a percentage of patient billings on top of it. Operators report a blended effective take in the high teens to low twenties once processing is included.

The difference is not a line item. It is a difference in who the platform's revenue belongs to. On a percentage model, the money your ad account earned on Tuesday is partly theirs by Wednesday, and you did the work.

Launch is $15,000 setup and $1,500 a month, 0 to 500 patients. Grow is $25,000 and $3,000, up to 2,000. Scale is $50,000 and $5,000, up to 5,000. Transaction fee is 3%, 2%, 1.5% by tier — Stripe's own published rate is 2.9% plus 30 cents, so at Scale you pay less than the processor charges.

LegitScript is included at $0 on every tier, filed and managed in 7 to 14 days. Consult fees apply in month one only. Refills never carry one, which matters because refills are where a subscription brand actually lives.

On PharmaBro your brand connects its own Stripe account through OAuth. Patient payments settle into it directly. We never hold your funds, never sit as merchant of record, and cannot delay a payout.

On Bask, Bask is the merchant of record. That means the payment relationship — and the stored card tokens — sit on their side of the line. Leaving is not a data migration; it is re-collecting card details from every active subscriber, and losing the ones who do not re-enter them.

PharmaBro exports everything — records, order history, card tokens — within 24 hours, any day you ask. No ticket, no negotiation, no exit interview.

PharmaBro opens a full branded clinic in 5 days. Bask implementations average 30 to 40.

That is four to six weeks of paid traffic you cannot run, at exactly the point your capital is committed and your creative is ready. At $50,000 a month in acquisition, waiting five weeks costs more than the entire first-year platform fee.

The speed comes from fulfillment being solved before you arrive: 30+ pre-integrated pharmacies with SKU and state-level routing already live, and LegitScript filed in parallel with the build rather than queued behind it.

Bask's developer SDK is genuinely more mature than most of this category, and SOC 2 Type II is already in hand. If you have an engineering team that intends to build deeply on top of the platform, that is a real advantage and worth paying for.

If extensibility is your first requirement and economics are your second, Bask is a defensible choice. For most DTC operators buying their own traffic, that order is reversed.

At 300 patients the gap is roughly $165,000 a year. At 3,000 it is nearly two million — and PharmaBro opens four to six weeks sooner, so the gap starts compounding while the alternative is still in implementation.

Published pricing. Your own Stripe. Zero revenue share. Live in 5 days. Unlimited brands from one account, and an in-house rebill engine that recovers another 0.5 to 1% every cycle.